Nalbuphine HCl 10mg/mL, 20mg/mL; soln for SC, IM or IV inj. Nalbuphine is an agonist at kappa opioid receptors and an antagonist at mu opioid receptors. The principal therapeutic action of ...
Completed enrollment of the Phase 2a RIVER trial in refractory chronic cough (RCC) with topline results expected in the first quarter of 2025 Reached 50% enrollment ...